Enter your search terms:

Aquestive Therapeutics to Present at H.C. Wainwright Global Life Sciences Conference

WARREN, N.J., March 25, 2019 /PRNewswire/ — Aquestive Therapeutics, Inc. (NASDAQ:AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products to solve therapeutic problems, today announced that management will present at the H.C. Wainwright Global Life Sciences Conference to be held in London, UK on April 7 – 9.

(PRNewsfoto/Aquestive Therapeutics)

Aquestive will present on Tuesday, April 9 at 3:20 p.m. BST. For more information, please visit investors.aquestive.com.

About Aquestive Therapeutics
Aquestive Therapeutics is a specialty pharmaceutical company that applies innovative technology to solve therapeutic problems and improve medicines for patients. Aquestive is advancing a late-stage proprietary product pipeline to treat CNS conditions and provide alternatives to invasively-administered standard of care therapies. The Company also collaborates with pharmaceutical partners to bring new molecules to market using proprietary, best-in-class technologies, like PharmFilm®, and proven capabilities for drug development and commercialization.

Media inquiries:
Christopher Hippolyte

Investor inquiries:
Stephanie Carrington

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/aquestive-therapeutics-to-present-at-hc-wainwright-global-life-sciences-conference-300818029.html

SOURCE Aquestive Therapeutics, Inc.

Latest comments

Sorry, the comment form is closed at this time.